Condition
Left Ventricular Thrombosis
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
100%
3 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
P 3 (3)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03232398Phase 3Completed
Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
NCT02982590Phase 3CompletedPrimary
Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus
NCT03926780Phase 3Completed
Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi
Showing all 3 trials